Multidrug-resistant (MDR) Gram-negative fermenters: “Our worst nightmare?”

References

• Garau G, Garcia-Saez I, Bebrone C, et al. Update of the standard numbering scheme for class B β-lactamases. Antimicrob Agents Chemother2004; 48:2347–2349
   Google Scholar
• Pitout JDD, Nordmann P. Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamasess (ESBLs) in the community. JAntimicrob Chemother2005; 56:52–59
   Google Scholar
• 3.Meyer L, Labuschagne CDJ, Ehlers MM, Dove MG, Weldhagen GF. Diversity of b/a-type genes in extended-spectrum β-lactamases producing Klebsiella pneumoniae isolated during 2003–2004 at Pretoria Academic Hospital. South Aff J Epidemiology Infect 2007;22 (1): 5–7
   Google Scholar
• Weldhagen GF, Poirel L, Nordmann P. Minireview. Ambler Class A extended spectrum β-lactamasess in Pseudomonas aeruginosa: Novel developments and clinical impact. Antimicrob Agents Chemother 2003; 47:2385–2392
   Google Scholar
• Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved standard M2-A9. Wayne, Pa: Clinical Laboratory Standards Institute, 2007
   Google Scholar
• Stevenson KB, Samore M, Barbera J, eta]. Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards. Dia8n116crobiol Infect Dis2003; 47:303–311
   Google Scholar
• Tenover FC, Mohammed MJ, Stelling J, eta]. Ability to laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. J Clin 116crobio12001; 39: 241–250
   Google Scholar
• Luzzaro F, Gesu G, Endimiani A, eta]. Performance in detection and reporting 13-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories. Diagn Microb InfectDis2006; 55:311–3118
   Google Scholar
• Brink AJ, Moolman J, Cruz da Silva M, Botha M and the National Antibiotic Surveillance Forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa: January-June 2006. SAff MedJ2007; 97:630–636
   Google Scholar
• Tumbrels M, Span T, Sanguinity M, et aL Bloodstream infections 3caused by Extended-Spectrum-β-lactamases-producing Klebsiella Pneumonia Risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother2006; 50: 498–504
   Google Scholar
• Wadula J, Von Gottberg A, Kilner D, eta]. Nosocomial outbreak of extended-spectrum β-lactamases producing Salmonella isangi in paediatric wards. Ped InfectDis J2006; 25:843–844
   Google Scholar
• Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000; 45: 183–189
   Google Scholar
• Saurina G, Quale JM, Manikal VM, eta]. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. JAntimicrobChemother2000; 45: 895–98
   Google Scholar
• Moolman GJJ, Jankowitz CE, Bezuidenhout S, eta]. Beta-lactamases in Enterobacteriaceae an ever-present threat. S Aff Med J 2006; 96: 331–334
   Google Scholar
• Wiener J, Quinn JP, Bradford PA, eta]. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JANV11999; 281: 517–523
   Google Scholar
• Bradford PA, Brat S, Urban C, eta]. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 ?-lactamases in New York City. Clin InfectDis2004; 39:55–60
   Google Scholar
• Elliott E, Brink AJ, Van Greune J, et al. In-vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with extended-spectrumβ-lactamases. Clin Infect Dis 2006;42: e95–8
   Google Scholar
• Segal H, Elisha BG. Resistance to -lactams, and reduced susceptibility to carbapenems, in clinical isolates of Klebsiella pneumoniae due to interplay between CTX-M-15 and altered outer membrane permeability. SouthAff JEpidemiol Infect2006; 21:41–44
   Google Scholar
• Richards G.A The therapeutic challenge of Gram-negative sepsis: Prolonging the lifespan of a scarce resource. Clinical Microbiology and Infection 2005; 11 (s6):18–25
   Google Scholar
• Govinden U, Mocktar C, Moodley P, eta]. CTX-M-37 in Salmonella enterica serotype Isangi from Durban, South Africa. hit J Antimicrob Agents2006; 28:288–291
   Google Scholar